Actively Recruiting
Stereotactic Radiotherapy for Treating Bone and Lymph Node Metastases in Advanced Therapy-Resistant Prostate Cancer
Led by Institut Cancerologie de l'Ouest · Updated on 2026-06-04
18
Participants Needed
1
Research Sites
113 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the maximum tolerated volume MTV of metastatic lesions in patients with high-volume metastatic prostate cancer that is resistant to therapy. This phase 1 study focuses on bone and lymph node metastases in patients whose cancer has progressed after androgen-receptor pathway inhibitors, chemotherapy, or other life-prolonging treatments. The goal is to determine how much tumor volume can be safely treated with stereotactic radiotherapy SRT to potentially extend the time without pain or tumor complications. Participants will receive stereotactic body radiotherapy SBRT targeting a subset of metastatic lesions prioritized by risk of causing pain or complications like fractures or spinal compression. The radiation dose regimens are 27 Gy over 3 fractions or 35 Gy over 5 fractions, spaced with at least 24 hours between sessions. The treatment volume will be escalated progressively until the maximum tolerated volume is reached, based on bone marrow reserve and tumor volume ratios. During the study, participants will undergo assessments including pain evaluation using the EVA scale, monitoring for radiotherapy-related toxicities, and tracking tumor-related complications or death for up to two years. Researchers will also determine the recommended irradiation volume for future studies. The total study duration includes a 12-week evaluation of MTV and extended follow-up for safety and clinical outcomes. Participants must comply with scheduled visits and examinations throughout the trial.
CONDITIONS
Brief Title
HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS)
Research Team
L
Loïg Vaugier, MD
L
Lucie Labarre
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here